文献速递神经免疫

多发性硬化患者维生素与膳食补充剂的使用:综述

Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.
PubMed 文献 · JAMA Neurol · 2018-01-01

本综述概述维生素与膳食补充剂在多发性硬化及其动物模型中的证据现状,重点关注近期研究,并讨论生物学合理性与安全性问题。多数人体试验规模小或非盲法,限制其推广性;生物素与维生素D正在大型随机临床试验中测试,硫辛酸与益生菌等补充剂亦有小型试验在进行或计划中。目前唯一有足够证据支持常规补充的维生素是维生素D,应避免维生素缺乏。

要点

  • 目前唯一有足够证据支持多发性硬化患者常规补充的维生素是维生素D。
  • 应避免维生素缺乏。
  • 临床医生应了解患者正在使用的补充剂,并告知已知疗效数据、潜在药物相互作用及不良反应。

核心结论

  • 目前唯一有足够证据支持多发性硬化患者常规补充的维生素是维生素D。
  • 应避免维生素缺乏。
  • 临床医生应了解患者正在使用的补充剂,并告知已知疗效数据、潜在药物相互作用及不良反应。
  • 鉴于美国膳食补充剂与维生素不受与处方药相同的监管,建议从具有美国药典(USP)认证的可靠制造商处购买。

研究设计与样本

  • 本综述提供维生素与膳食补充剂在多发性硬化及其动物模型中作用证据现状的更新概述,重点关注近期研究。

主要发现

  • 多数人体试验规模小或非盲法,限制其推广性。
  • 生物素与维生素D目前正在大型随机临床试验中测试。
  • 硫辛酸与益生菌等其他补充剂的小型试验正在进行或计划中。
  • 这些研究结果可能有助于指导临床建议。

临床怎么用

  • 目前唯一有足够证据支持多发性硬化患者常规补充的维生素是维生素D。
  • 应避免维生素缺乏。
  • 临床医生应了解患者正在使用的补充剂,并告知已知疗效数据、潜在药物相互作用及不良反应。
  • 建议从具有美国药典(USP)认证的可靠制造商处购买维生素与补充剂。

局限性

  • 多数人体试验规模小或非盲法,限制其推广性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Surveys of patients with multiple sclerosis report that most are interested in modifying their diet and using supplements to potentially reduce the severity and symptoms of the disease. This review provides an updated overview of the current state of evidence for the role that vitamins and dietary supplements play in multiple sclerosis and its animal models, with an emphasis on recent studies, and addresses biological plausibility and safety issues. OBSERVATIONS: Several vitamins and dietary supplements have been recently explored both in animal models and by patients with multiple sclerosis. Most human trials have been small or nonblinded, limiting their generalizability. Biotin and vitamin D are currently being tested in large randomized clinical trials. Smaller trials are ongoing or planned for other supplements such as lipoic acid and probiotics. The results of these studies may help guide clinical recommendations. CONCLUSIONS AND RELEVANCE: At the present time, the only vitamin with sufficient evidence to support routine supplementation for patients with multiple sclerosis is vitamin D. Vitamin deficiencies should be avoided. It is important for clinicians to know which supplements their patients are taking and to educate patients on any known efficacy data, along with any potential medication interactions and adverse effects of individual supplements. Given that dietary supplements and vitamins are not subject to the same regulatory oversight as prescription pharmaceuticals in the United States, it is recommended that vitamins and supplements be purchased from reputable manufacturers with the United States Pharmacopeia designation.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Evans E, Piccio L, Cross AH, et al. Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review. JAMA Neurol. 2018. PMID: 29710293. doi:10.1001/jamaneurol.2018.0611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。